For animal use only.
Clostrivax O is an adjuvanted multi-component vaccine for the active immunisation of sheep against diseases caused by Clostridium perfringens type A (enterotoxaemia, gas gangrene, sudden death syndrome), C. perfringens type D (enterotoxaemia, pulpy kidney), C. tetani (tetanus), C. novyi type A (swollen head), C. novyi type B (black disease, infectious necrotic hepatitis), C. chauvoei (black leg, black quarter), Bibersteinia trehalosi (pasteurellosis, septicaemia), C. septicum (malignant oedema, braxy) and Mannheimia haemolytica type A1 (pneumonia).
COMPOSITION
Clostrivax O contains toxoids from C. perfringens type A and D, C. tetani, C. novyi types A and B, C. septicum, M. haemolytica type A1 leukotoxin and formalin inactivated C. chauvoei and B. trehalosi anacultures.
STORAGE
Store in a refrigerator between 2°C and 8°C. Protect from light. Do not freeze. Protect from high temperatures and direct sunlight. Do not use after the expiry date printed on the container. Do not store any vials into which a needle or other device has been inserted, for future use.
DIRECTIONS FOR USE - USE ONLY AS DIRECTED
- Shake gently before use by inverting the vial several times.
- Use sterile needles and syringes to administer Clostrivax O.
- Inject sheep subcutaneously on the side of the neck. DO NOT deviate from the recommended route and injection site location.
- Lambs may be vaccinated from 2 months of age and older.
- Clostrivax O is safe to use in ewes in all trimesters of pregnancy or lambs nursing pregnant ewes.
- Ewes sensitised within the last 12 months should be vaccinated 2-6 weeks before calving is due to commence. This provides passive protection to the lamb, via colostrum, for up to 8 weeks.
DOSAGE
- Inject 2 ml via the subcutaneous route, on the side of the neck.
- A booster vaccination of 2 ml should be administered 3-4 weeks later. Annual revaccination is recommended thereafter.
PACKING SIZE AND ORDERING CODE
250 ml (LVS06230)
100 ml (LVS06849)
Reg. no. G4484 (36/1947)
Reg. holder: Vetvax (Pty) Ltd, Reg. no. 2004/035302/07, 442 Rigel Avenue South, Erasmusrand, Pretoria | Tel. 012 349 2772
Clostrivax O
- Withdrawal period: Do not slaughter animals for human consumption within 21 days of vaccination.
- Usually no marked reactions follow vaccination, although a transient swelling may appear at the site of inoculation, and some animals may show a moderate rise of temperature for one or two days.
- Do not use in animal species other than those indicated.
- Do not administer to animals in poor or extremely poor body condition.
- KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
- Although this product has been extensively tested under a large variety of conditions, failure thereof may ensue for a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder and the registrar.
- Do not over- or under-dose the vaccine.
- In case of accidental self-injection, seek medical advice immediately and showthe package leaflet or the label to the physician.
- Do not inject intravenously.
- Follow standard sterile procedures during administration of injections.
- Do not mix this product with any other vaccines or medicines.
- Avoid contact with skin, eyes and mouth.
- Do not eat, drink or smoke whilst handling the product.
- Do not contaminate rivers, dams or any water sources with containers or waste.
- Dispose of all containers and all unused contents in accordance with the local law.
- Do not use disinfectants or antiseptics to sterilise any equipment.
- Wear protective clothing, masks, gloves, etc. according to hazard standards.
- Adhere to the vaccination programme to obtain optimum results.
- Due to the adjuvant used, local reactions may occur in some animals at the injection site. They will disappear after a few days. If you notice any serious effects not mentioned in the package leaflet, please inform your veterinarian.